SlideShare une entreprise Scribd logo
1  sur  21
Télécharger pour lire hors ligne
SUDDEN CARDIAC
ARREST
DR. D. B. PAHLAJANI
MD,FACC,FSCAI
Consultant Cardiologist & Chief of Cardiac Catherization
Laboratory, Breach Candy Hospital Mumbai
Sudden Cardiac Death: Definition
• “Sudden cardiac death is natural death due to
cardiac causes, heralded by abrupt loss of
consciousness within one hour of the onset of
acute symptoms, as in an individual with or
without known pre-existing heart disease, but in
whom the time and mode of death are
unexpected”.
Gaziano JM in Braunwald Zipes Libby Heart Disease,6th
ed.W.B. Saunders 2001:1
The Epidemic of Sudden Cardiac
Arrest
Sudden Cardiac Arrest
• Accounts for 63% of all cardiac related deaths in the US1
.
• One of the most common causes of death in developed countries:
1
MMWR. Vol 51(6) Feb. 15, 2002. 2
Braunwald E, ed. Heart Disease: A
Textbook of Cardiovascular Medicine. 5th
Ed. New York: WB
Saunders. 1997: 742-779. 3
Zheng Z. Circulation. 2001;104:2158-
2163. 4
Vreede-Swagemakers JJ et al. J Am Coll Cardiol 1997; 30:
1500-1505.
GeographyGeography IncidenceIncidence SurvivalSurvival
Worldwide 3,000,0002
<1%2
US 450,0003
~5%2
W. Europe 400,0004
<5%4
Magnitude of SCA in the US
42,156
450,000
40,600
157,400
167,366
1
U.S. Census Bureau, Statistical Abstract of the United States: 2001.
2
American Cancer Society, Inc., Surveillance Research, Cancer Facts and Figures 2001.
3
2002 Heart and Stroke Statistical Update, American Heart Association.
AIDS1
Breast
Cancer2
Lung
Cancer2
Stroke3
Sudden
Cardiac
Arrest 4
SCA claims
more lives each
year than these
other diseases
combined
The #1 Cause
of Death
Resuscitated Cardiac Arrest-
Prognosis
• 48749 STEMI
• 5308 (10.9%) CA
• 157 (29.3%) died on the day of admission
• Increased risk of death during index hosp (HR
3.69
• 30 days HR 1.5
• Following 30 days HR 1.1
Albert Alahmar et al,Heart,April 24,2014
Etiology of Sudden Cardiac Death
Coronary Heart Disease
• An estimated 13 million people had CHD in the U.S. in 2002. 1
• Sudden death was the first manifestation of coronary heart
disease in 50% of men and 63% of women. 1
• CHD accounts for at least 80% of sudden cardiac deaths in
Western cultures.3
1
American Heart Association. Heart Disease and Stroke Statistics—
2003 Update. Dallas, Tex.: American Heart Association; 2002.
2
Adapted from Heikki et al. N Engl J Med, Vol. 345, No. 20, 2001.
3
Myerberg RJ. Heart Disease, A Textbook of Cardiovascular Medicine.
6th
ed. P. 895.
Etiology of Sudden Cardiac DeathEtiology of Sudden Cardiac Death2,32,3OTHERS
* ion-channel
abnormalities,
valvular or
congenital
heart disease,
other causes
80%
Coronary
Heart Disease
15%
Cardiomyopathy
5% Others*
Arrhythmic Cause of SCD
Albert CM. Circulation. 2003;107:2096-2101.
12%
Other Cardiac
Cause
88%
Arrhythmic
Cause
Bayés de Luna A. Am Heart J. 1989;117:151-159.
Underlying Arrhythmias of
Sudden Cardiac Arrest
Bradycardia
17%
VT
62% Primary VF
8%
Torsades de Pointes
13%
Heart Failure
and Sudden Cardiac Death
Incidence of SCD in Specific Populations
and Annual SCD Numbers
Adapted from: Myerburg RJ. Sudden Cardiac Death: Exploring the Limits of Our
Knowledge. J Cardiovasc Electrophysiol Vol. 12, pp. 369-381, March 2001.
300,000200,000100,0000
Incidence of Sudden
Deaths Per Year
(number)
Multiple risk
subgroups
Patients with any
previous coronary
event
Patients with ejection
fraction <35% or CHF
Cardiac arrest, VT/VF
survivors
High-risk post-MI
subgroups
General adult
population
3025201050
Incidence of Sudden Death
(% of group)
MADIT, MUSTT, MADIT II
AVID, CASH, CIDS
SCD-HeFT
Heart Failure and Sudden Death
5
8
7
15
0
2
4
6
8
10
12
14
16
Age-adjustedannual
rate/1000
Women Men
SCD-NoCHF SCD-CHF
During a 39-year follow-up of subjects in the Framingham Heart Study,
the presence of CHF significantly increased sudden death and overall
mortality in both men and women.1
1 Redrawn from Kannel WB, Wilson PWF, D'Agostino RB, Cobb J. Sudden coronary death in women. Am Heart J
1998 Aug; 136: 205-212
60-115% increase
in sudden death if
CHF present.
Severity of Heart Failure
Modes of Death
MERIT-HF Study Group. Effect of Metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL randomizedMERIT-HF Study Group. Effect of Metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL randomized
intervention trial in congestive heart failure (MERIT-HF).intervention trial in congestive heart failure (MERIT-HF). LANCET.LANCET. 1999;353:2001-07.1999;353:2001-07.
12%12%
24%24%
64%64%
CHFCHF
OtherOther
SuddenSudden
DeathDeath
n = 103n = 103
NYHA IINYHA II
26%26%
15%15%
59%59%
CHFCHF
OtherOther
SuddenSudden
DeathDeath
n = 103n = 103
NYHA IIINYHA III
56%56%
11%11%
33%33%
CHFCHF
OtherOther
SuddenSudden
DeathDeath
n = 27n = 27
NYHA IVNYHA IV
The greatest opportunity for
SCD prevention is in patients
that have mild to moderate
CHF.
1
Moss A, et al. N Engl J Med. 1996;335:1933–40.
2
Buxton, A, et al; N Engl J Med. 1999;341:1882–90.
3
AVID Investigators; N Engl J Med. 1997;337:1576–83.
4
Moss, A. et al; N Engl J Med. 2002;346:877–83.
MADIT1
(n=196)
MADIT-II2
(n=1232) MUSTT3
(n=704)
Age 63 64 68
LVEF 0.26 0.23 0.30
NYHA I 37% 39% 37%
NYHA II or III 63% 57% 63%
NYHA IV Excluded 4% Excluded
CAD (%) 100 100 100
Previous CABG/PTCA (%) 73/27 60/45 56/23
Post-MI trials are not heart
failure trials but…
… there’s a high % of symptomatic heart failure and LV
dysfunction in the post-MI trials
Sudden cardiac death
 150 Sudden Cardiac Deaths per 100,000 persons
annually in industrialized world.
 40% of SCDs occur in people with no prior history of
heart disease.
 SCD accounts for more than 50% of cardiac mortality.
 Autopsies revealed 90% victims have CAD.
 Age above 40 yrs.
Incidence of Sudden Cardiac Death
 Prior Episode of V.TACH
 Low LVEF.
 Previous Myocardial Infarction.
 Coronary Artery Disease
 Family History of SCD.
 Cardiomyopathy
 Congestive Heart Failure
 Long QT Syndrome.
 Right Ventricular Dysplasia.
Risk Factors of Sudden Cardiac Death
 % Witnessed VF Patients Surviving to Hospital Discharge
49%
7%
74%
0%
10%
20%
30%
40%
50%
60%
70%
80%
Receiving shock <3
min. after collapse
(26 / 35)
Receiving shock >3
min. after collapse
(27 / 55)
National average
Sudden Cardiac Arrest (SCA)
“Chain of Survival” Third link – Early
Defibrillation
SCD Rates in Post-MI Patients
with LV Dysfunction
21
19.8
14
10
7
16 16
12
9.4
28
18
20
28
0
10
20
30
TRACE CAPRICORN EMIAT MADIT MUSTT
Inducible
MUSTT
Registry
MADIT II*
ControlGroupMortalityat2years
Total Mortality
Arrhythmic Mortality
N Engl J Med 1995; 333: 1670-6. CAPRICORN: Lancet 2001; 357: 1385-90.
Lancet 1997; 349: 667-74. MADIT:
Moss AJ. N Engl J Med. 1996;335:1933-40.
MUSTT: 1) Buxton AE. N Engl J Med. 1999;341:1882-90. 2) Buxton AE, et al. N Engl
J Med 2000; 342: 1937-45. MADIT-II: 1) Moss AJ. N Engl J Med. 2002;346:877-83,
2) Arrhythmic mortality data from: Moss AJ. Presented at ACC Late Breaking Clinical
Trials, March 2002.
Total Mortality ~20-30%; SCD accounts for ~50% of the total deaths.
SCD Rates in CHF Patients with LV
Dysfunction
17
8
20
15
9
19
7
6
4
11
0
10
20
30
CHF-STAT GESICA SOLVD V-HeFT I MERIT-HF CIBIS-II CARVEDILOL-US
ControlGroupMortality
Total Mortality
Sudden Death
Total Mortality ~15-40%; SCD accounts for ~50% of the total deaths.
12 months 16 months41.4 months 27 months13 months45 months 6 months
N Engl J Med 1995; 333: 77-82. GESICA: Doval, HC. Lancet. 1994. Circulation. 1999; 100: 1311-1315.
Lancet 1999; 353: 2001-07. N Engl J Med 1996; 334: 1349-55.

Contenu connexe

Tendances

Management of VENTRICULAR TACHYCARDIA (VT)
Management of VENTRICULAR TACHYCARDIA (VT)Management of VENTRICULAR TACHYCARDIA (VT)
Management of VENTRICULAR TACHYCARDIA (VT)Malleswara rao Dangeti
 
Primary Prevention Of Sudden Cardiac Death - Role Of Devices
Primary Prevention Of Sudden Cardiac Death - Role Of DevicesPrimary Prevention Of Sudden Cardiac Death - Role Of Devices
Primary Prevention Of Sudden Cardiac Death - Role Of DevicesArindam Pande
 
Ischemia trial
Ischemia trialIschemia trial
Ischemia trialDrvasanthi
 
Acute coronary syndromes
 Acute coronary syndromes Acute coronary syndromes
Acute coronary syndromesRaniya Khalid
 
Approach to patient with Dilated Cardiomyopathy
Approach to patient with Dilated CardiomyopathyApproach to patient with Dilated Cardiomyopathy
Approach to patient with Dilated CardiomyopathyNizam Uddin
 
Cardiac resynchronization therapy
Cardiac resynchronization therapyCardiac resynchronization therapy
Cardiac resynchronization therapyDr.Sayeedur Rumi
 
Prediction and Prevention in Sudden Cardiac Death
Prediction and Prevention in Sudden Cardiac DeathPrediction and Prevention in Sudden Cardiac Death
Prediction and Prevention in Sudden Cardiac DeathApollo Hospitals
 
Cardiac arrest and sudden cardiac death
Cardiac arrest and sudden cardiac deathCardiac arrest and sudden cardiac death
Cardiac arrest and sudden cardiac deathShreyash Trived
 
Sudden Cardiac Death
Sudden Cardiac DeathSudden Cardiac Death
Sudden Cardiac Deathjcm MD
 
Chest Pain Evaluation
Chest Pain EvaluationChest Pain Evaluation
Chest Pain EvaluationRashidi Ahmad
 
Infective Endocarditis
Infective EndocarditisInfective Endocarditis
Infective Endocarditishospital
 

Tendances (20)

Management of VENTRICULAR TACHYCARDIA (VT)
Management of VENTRICULAR TACHYCARDIA (VT)Management of VENTRICULAR TACHYCARDIA (VT)
Management of VENTRICULAR TACHYCARDIA (VT)
 
HOCM Hypertrophic cardiomyopathy
HOCM Hypertrophic cardiomyopathyHOCM Hypertrophic cardiomyopathy
HOCM Hypertrophic cardiomyopathy
 
Primary Prevention Of Sudden Cardiac Death - Role Of Devices
Primary Prevention Of Sudden Cardiac Death - Role Of DevicesPrimary Prevention Of Sudden Cardiac Death - Role Of Devices
Primary Prevention Of Sudden Cardiac Death - Role Of Devices
 
Ischemia trial
Ischemia trialIschemia trial
Ischemia trial
 
Echocardiography of CHD in Adults
Echocardiography of CHD in AdultsEchocardiography of CHD in Adults
Echocardiography of CHD in Adults
 
Acute coronary syndromes
 Acute coronary syndromes Acute coronary syndromes
Acute coronary syndromes
 
Approach to patient with Dilated Cardiomyopathy
Approach to patient with Dilated CardiomyopathyApproach to patient with Dilated Cardiomyopathy
Approach to patient with Dilated Cardiomyopathy
 
Nst acs imrose
Nst acs imroseNst acs imrose
Nst acs imrose
 
Cardiac resynchronization therapy
Cardiac resynchronization therapyCardiac resynchronization therapy
Cardiac resynchronization therapy
 
Inoca and minoca
Inoca and minocaInoca and minoca
Inoca and minoca
 
Prediction and Prevention in Sudden Cardiac Death
Prediction and Prevention in Sudden Cardiac DeathPrediction and Prevention in Sudden Cardiac Death
Prediction and Prevention in Sudden Cardiac Death
 
Cardiac arrest and sudden cardiac death
Cardiac arrest and sudden cardiac deathCardiac arrest and sudden cardiac death
Cardiac arrest and sudden cardiac death
 
Sudden Cardiac Death
Sudden Cardiac DeathSudden Cardiac Death
Sudden Cardiac Death
 
Chest Pain Evaluation
Chest Pain EvaluationChest Pain Evaluation
Chest Pain Evaluation
 
Long QT Syndrome
Long QT SyndromeLong QT Syndrome
Long QT Syndrome
 
Stent Thrombosis
Stent ThrombosisStent Thrombosis
Stent Thrombosis
 
Ventricular tachycardia
Ventricular tachycardiaVentricular tachycardia
Ventricular tachycardia
 
Infective Endocarditis
Infective EndocarditisInfective Endocarditis
Infective Endocarditis
 
Brugada syndrome
Brugada syndromeBrugada syndrome
Brugada syndrome
 
Implication of 3D Mapping in EP
Implication of 3D Mapping in EP Implication of 3D Mapping in EP
Implication of 3D Mapping in EP
 

Similaire à Sudden cardiac death

CARDIOMYOPATHIES-by MWEBAZA VICTOR.pptx
CARDIOMYOPATHIES-by MWEBAZA VICTOR.pptxCARDIOMYOPATHIES-by MWEBAZA VICTOR.pptx
CARDIOMYOPATHIES-by MWEBAZA VICTOR.pptxDr. MWEBAZA VICTOR
 
Sudden cardiac death in structurally normal hearts
Sudden cardiac death in structurally normal heartsSudden cardiac death in structurally normal hearts
Sudden cardiac death in structurally normal heartsYasmeen Kamal
 
CARDIOMYOPATHIES-by MWEBAZA VICTOR.pptx
CARDIOMYOPATHIES-by MWEBAZA VICTOR.pptxCARDIOMYOPATHIES-by MWEBAZA VICTOR.pptx
CARDIOMYOPATHIES-by MWEBAZA VICTOR.pptxDr. MWEBAZA VICTOR
 
SUDDEN CARDIAC DEATH.pptx
SUDDEN CARDIAC DEATH.pptxSUDDEN CARDIAC DEATH.pptx
SUDDEN CARDIAC DEATH.pptxvarshithkumar4
 
RỐI LOẠN NHỊP THẤT TRONG NHỒI MÁU CƠ TIM
RỐI LOẠN NHỊP THẤT TRONG NHỒI MÁU CƠ TIMRỐI LOẠN NHỊP THẤT TRONG NHỒI MÁU CƠ TIM
RỐI LOẠN NHỊP THẤT TRONG NHỒI MÁU CƠ TIMSoM
 
EMGuideWire's Radiology Reading Room: Stress-Induced Cardiomyopathy
EMGuideWire's Radiology Reading Room: Stress-Induced CardiomyopathyEMGuideWire's Radiology Reading Room: Stress-Induced Cardiomyopathy
EMGuideWire's Radiology Reading Room: Stress-Induced CardiomyopathySean M. Fox
 
Miocardiopatia hipertrofica
Miocardiopatia hipertroficaMiocardiopatia hipertrofica
Miocardiopatia hipertroficaCardioTeca
 
Cardiac Channelopathies atul.pptx
Cardiac Channelopathies atul.pptxCardiac Channelopathies atul.pptx
Cardiac Channelopathies atul.pptxAtul Sharma
 
The Long QT Syndrome: Overview and Management The Long QT Syndrome: Overvie...
The Long QT Syndrome: Overview and Management 	 The Long QT Syndrome: Overvie...The Long QT Syndrome: Overview and Management 	 The Long QT Syndrome: Overvie...
The Long QT Syndrome: Overview and Management The Long QT Syndrome: Overvie...MedicineAndFamily
 
Fourth universal definition of myocardial
Fourth universal definition of myocardialFourth universal definition of myocardial
Fourth universal definition of myocardialRamachandra Barik
 
Cardiovascular Disease prevention - Epidemiology, cardio,healt
Cardiovascular Disease prevention - Epidemiology, cardio,healtCardiovascular Disease prevention - Epidemiology, cardio,healt
Cardiovascular Disease prevention - Epidemiology, cardio,healtCardiovascularprevention
 

Similaire à Sudden cardiac death (20)

CARDIOMYOPATHIES-by MWEBAZA VICTOR.pptx
CARDIOMYOPATHIES-by MWEBAZA VICTOR.pptxCARDIOMYOPATHIES-by MWEBAZA VICTOR.pptx
CARDIOMYOPATHIES-by MWEBAZA VICTOR.pptx
 
Ventricular fibrillation eMedicine Article
Ventricular fibrillation eMedicine ArticleVentricular fibrillation eMedicine Article
Ventricular fibrillation eMedicine Article
 
Out of hospital sudden cardiac death(scd)
Out of hospital sudden cardiac death(scd)Out of hospital sudden cardiac death(scd)
Out of hospital sudden cardiac death(scd)
 
Out of hospital 2
Out of hospital 2Out of hospital 2
Out of hospital 2
 
Scd
ScdScd
Scd
 
Sudden cardiac death in structurally normal hearts
Sudden cardiac death in structurally normal heartsSudden cardiac death in structurally normal hearts
Sudden cardiac death in structurally normal hearts
 
CARDIOMYOPATHIES-by MWEBAZA VICTOR.pptx
CARDIOMYOPATHIES-by MWEBAZA VICTOR.pptxCARDIOMYOPATHIES-by MWEBAZA VICTOR.pptx
CARDIOMYOPATHIES-by MWEBAZA VICTOR.pptx
 
SUDDEN CARDIAC DEATH.pptx
SUDDEN CARDIAC DEATH.pptxSUDDEN CARDIAC DEATH.pptx
SUDDEN CARDIAC DEATH.pptx
 
Ischemic stroke
Ischemic strokeIschemic stroke
Ischemic stroke
 
Bs va
Bs vaBs va
Bs va
 
RỐI LOẠN NHỊP THẤT TRONG NHỒI MÁU CƠ TIM
RỐI LOẠN NHỊP THẤT TRONG NHỒI MÁU CƠ TIMRỐI LOẠN NHỊP THẤT TRONG NHỒI MÁU CƠ TIM
RỐI LOẠN NHỊP THẤT TRONG NHỒI MÁU CƠ TIM
 
Out of hospital
Out of hospitalOut of hospital
Out of hospital
 
Out of hospital sudden cardiac death (scd) declining or escalating
Out of hospital sudden cardiac death (scd) declining or escalatingOut of hospital sudden cardiac death (scd) declining or escalating
Out of hospital sudden cardiac death (scd) declining or escalating
 
EMGuideWire's Radiology Reading Room: Stress-Induced Cardiomyopathy
EMGuideWire's Radiology Reading Room: Stress-Induced CardiomyopathyEMGuideWire's Radiology Reading Room: Stress-Induced Cardiomyopathy
EMGuideWire's Radiology Reading Room: Stress-Induced Cardiomyopathy
 
Miocardiopatia hipertrofica
Miocardiopatia hipertroficaMiocardiopatia hipertrofica
Miocardiopatia hipertrofica
 
Cardiac Channelopathies atul.pptx
Cardiac Channelopathies atul.pptxCardiac Channelopathies atul.pptx
Cardiac Channelopathies atul.pptx
 
The Long QT Syndrome: Overview and Management The Long QT Syndrome: Overvie...
The Long QT Syndrome: Overview and Management 	 The Long QT Syndrome: Overvie...The Long QT Syndrome: Overview and Management 	 The Long QT Syndrome: Overvie...
The Long QT Syndrome: Overview and Management The Long QT Syndrome: Overvie...
 
Fourth universal definition of myocardial
Fourth universal definition of myocardialFourth universal definition of myocardial
Fourth universal definition of myocardial
 
SYNCOPE..pptx
SYNCOPE..pptxSYNCOPE..pptx
SYNCOPE..pptx
 
Cardiovascular Disease prevention - Epidemiology, cardio,healt
Cardiovascular Disease prevention - Epidemiology, cardio,healtCardiovascular Disease prevention - Epidemiology, cardio,healt
Cardiovascular Disease prevention - Epidemiology, cardio,healt
 

Plus de cardiositeindia

NSTEMI Invasive Treatment: Rationale and Timing
NSTEMI Invasive Treatment: Rationale and TimingNSTEMI Invasive Treatment: Rationale and Timing
NSTEMI Invasive Treatment: Rationale and Timingcardiositeindia
 
Statins for primary prevention in Indians
Statins for primary prevention in IndiansStatins for primary prevention in Indians
Statins for primary prevention in Indianscardiositeindia
 
How to choose drugs in pulmonary arterial hypertension
How to choose drugs in pulmonary arterial hypertensionHow to choose drugs in pulmonary arterial hypertension
How to choose drugs in pulmonary arterial hypertensioncardiositeindia
 
Home based oxygen therapy for severe pulmonary hypertension
Home based oxygen therapy for severe pulmonary hypertensionHome based oxygen therapy for severe pulmonary hypertension
Home based oxygen therapy for severe pulmonary hypertensioncardiositeindia
 
Choosing antiplatelet therapy before during and after hosp for acs
Choosing antiplatelet therapy before during and after hosp for acsChoosing antiplatelet therapy before during and after hosp for acs
Choosing antiplatelet therapy before during and after hosp for acscardiositeindia
 
Benefits of hypertension control
Benefits of hypertension controlBenefits of hypertension control
Benefits of hypertension controlcardiositeindia
 
Coronary CTA: The test of choice for obstructive CAD.
Coronary CTA: The test of choice for obstructive CAD.Coronary CTA: The test of choice for obstructive CAD.
Coronary CTA: The test of choice for obstructive CAD.cardiositeindia
 
Investigating stable IHD- Treadmill, Dobutamine stress echo or Stress thallium
Investigating stable IHD- Treadmill, Dobutamine stress echo or Stress thalliumInvestigating stable IHD- Treadmill, Dobutamine stress echo or Stress thallium
Investigating stable IHD- Treadmill, Dobutamine stress echo or Stress thalliumcardiositeindia
 
What to choose in stable CAD- Medical therapy only or PCI or CABG?
What to choose in stable CAD- Medical therapy only or PCI or CABG?What to choose in stable CAD- Medical therapy only or PCI or CABG?
What to choose in stable CAD- Medical therapy only or PCI or CABG?cardiositeindia
 
Coronary artery disease in indians: Glimpses from Indian data.
Coronary artery disease in indians: Glimpses from Indian data.Coronary artery disease in indians: Glimpses from Indian data.
Coronary artery disease in indians: Glimpses from Indian data.cardiositeindia
 
Beta blockers in SIHD: Yes, all patients should receive them !
Beta blockers in SIHD: Yes, all patients should receive them !Beta blockers in SIHD: Yes, all patients should receive them !
Beta blockers in SIHD: Yes, all patients should receive them !cardiositeindia
 
Stable ischemic heart disease how is it different from acs..
Stable ischemic heart disease how is it different from acs..Stable ischemic heart disease how is it different from acs..
Stable ischemic heart disease how is it different from acs..cardiositeindia
 
Mild heart failure (nyha i and ii) patients should not receive crt
Mild heart failure (nyha i and ii) patients should not receive crtMild heart failure (nyha i and ii) patients should not receive crt
Mild heart failure (nyha i and ii) patients should not receive crtcardiositeindia
 
All patients 40 days post mi should receive icd
All patients 40 days post mi should receive icdAll patients 40 days post mi should receive icd
All patients 40 days post mi should receive icdcardiositeindia
 
Acute rv failure physiology to management
Acute rv failure  physiology to managementAcute rv failure  physiology to management
Acute rv failure physiology to managementcardiositeindia
 
Hypertension guidelines ESH ESC 2013
Hypertension guidelines ESH ESC 2013Hypertension guidelines ESH ESC 2013
Hypertension guidelines ESH ESC 2013cardiositeindia
 
Hypertension management- Angina IHD
Hypertension management- Angina IHDHypertension management- Angina IHD
Hypertension management- Angina IHDcardiositeindia
 

Plus de cardiositeindia (20)

NSTEMI Invasive Treatment: Rationale and Timing
NSTEMI Invasive Treatment: Rationale and TimingNSTEMI Invasive Treatment: Rationale and Timing
NSTEMI Invasive Treatment: Rationale and Timing
 
Statins for primary prevention in Indians
Statins for primary prevention in IndiansStatins for primary prevention in Indians
Statins for primary prevention in Indians
 
How to choose drugs in pulmonary arterial hypertension
How to choose drugs in pulmonary arterial hypertensionHow to choose drugs in pulmonary arterial hypertension
How to choose drugs in pulmonary arterial hypertension
 
Home based oxygen therapy for severe pulmonary hypertension
Home based oxygen therapy for severe pulmonary hypertensionHome based oxygen therapy for severe pulmonary hypertension
Home based oxygen therapy for severe pulmonary hypertension
 
Choosing antiplatelet therapy before during and after hosp for acs
Choosing antiplatelet therapy before during and after hosp for acsChoosing antiplatelet therapy before during and after hosp for acs
Choosing antiplatelet therapy before during and after hosp for acs
 
Benefits of hypertension control
Benefits of hypertension controlBenefits of hypertension control
Benefits of hypertension control
 
Coronary CTA: The test of choice for obstructive CAD.
Coronary CTA: The test of choice for obstructive CAD.Coronary CTA: The test of choice for obstructive CAD.
Coronary CTA: The test of choice for obstructive CAD.
 
Investigating stable IHD- Treadmill, Dobutamine stress echo or Stress thallium
Investigating stable IHD- Treadmill, Dobutamine stress echo or Stress thalliumInvestigating stable IHD- Treadmill, Dobutamine stress echo or Stress thallium
Investigating stable IHD- Treadmill, Dobutamine stress echo or Stress thallium
 
What to choose in stable CAD- Medical therapy only or PCI or CABG?
What to choose in stable CAD- Medical therapy only or PCI or CABG?What to choose in stable CAD- Medical therapy only or PCI or CABG?
What to choose in stable CAD- Medical therapy only or PCI or CABG?
 
Coronary artery disease in indians: Glimpses from Indian data.
Coronary artery disease in indians: Glimpses from Indian data.Coronary artery disease in indians: Glimpses from Indian data.
Coronary artery disease in indians: Glimpses from Indian data.
 
Beta blockers in SIHD: Yes, all patients should receive them !
Beta blockers in SIHD: Yes, all patients should receive them !Beta blockers in SIHD: Yes, all patients should receive them !
Beta blockers in SIHD: Yes, all patients should receive them !
 
Beta blockers in sihd
Beta blockers in sihdBeta blockers in sihd
Beta blockers in sihd
 
Stable ischemic heart disease how is it different from acs..
Stable ischemic heart disease how is it different from acs..Stable ischemic heart disease how is it different from acs..
Stable ischemic heart disease how is it different from acs..
 
Mild heart failure (nyha i and ii) patients should not receive crt
Mild heart failure (nyha i and ii) patients should not receive crtMild heart failure (nyha i and ii) patients should not receive crt
Mild heart failure (nyha i and ii) patients should not receive crt
 
All patients 40 days post mi should receive icd
All patients 40 days post mi should receive icdAll patients 40 days post mi should receive icd
All patients 40 days post mi should receive icd
 
Acute rv failure physiology to management
Acute rv failure  physiology to managementAcute rv failure  physiology to management
Acute rv failure physiology to management
 
Statin combinations
Statin combinationsStatin combinations
Statin combinations
 
Hypertension guidelines ESH ESC 2013
Hypertension guidelines ESH ESC 2013Hypertension guidelines ESH ESC 2013
Hypertension guidelines ESH ESC 2013
 
Anticoagulation in pci
Anticoagulation in pciAnticoagulation in pci
Anticoagulation in pci
 
Hypertension management- Angina IHD
Hypertension management- Angina IHDHypertension management- Angina IHD
Hypertension management- Angina IHD
 

Dernier

Eating Disorders in Athletes I Sports Psychology
Eating Disorders in Athletes I Sports PsychologyEating Disorders in Athletes I Sports Psychology
Eating Disorders in Athletes I Sports Psychologyshantisphysio
 
Empathy Is a Stress Response - Choose Compassion instead
Empathy Is a Stress Response - Choose Compassion insteadEmpathy Is a Stress Response - Choose Compassion instead
Empathy Is a Stress Response - Choose Compassion insteadAlex Clapson
 
LEUKODYSTROPHY FINAL.pptx sms medical jaipur
LEUKODYSTROPHY FINAL.pptx sms medical jaipurLEUKODYSTROPHY FINAL.pptx sms medical jaipur
LEUKODYSTROPHY FINAL.pptx sms medical jaipurdineshdandia
 
CECT NECK NECK ANGIOGRAPHY CAROTID ANGIOGRAPHY
CECT NECK NECK ANGIOGRAPHY CAROTID ANGIOGRAPHYCECT NECK NECK ANGIOGRAPHY CAROTID ANGIOGRAPHY
CECT NECK NECK ANGIOGRAPHY CAROTID ANGIOGRAPHYRMC
 
LARYNGEAL CANCER.pptx Prepared by Neha Kewat
LARYNGEAL CANCER.pptx  Prepared by Neha KewatLARYNGEAL CANCER.pptx  Prepared by Neha Kewat
LARYNGEAL CANCER.pptx Prepared by Neha KewatNehaKewat
 
Blood(The Applied Physiology) for Nurses.pptx
Blood(The Applied Physiology) for Nurses.pptxBlood(The Applied Physiology) for Nurses.pptx
Blood(The Applied Physiology) for Nurses.pptxNagamani Manjunath
 
Experience the Power of Chiropractic in Maui
Experience the Power of Chiropractic in MauiExperience the Power of Chiropractic in Maui
Experience the Power of Chiropractic in MauiCentral Maui Chiropractic
 
Govt releases guidelines to curb unethical pharma sector practices.pdf
Govt releases guidelines to curb unethical pharma sector practices.pdfGovt releases guidelines to curb unethical pharma sector practices.pdf
Govt releases guidelines to curb unethical pharma sector practices.pdfCompetitionPedia
 
21 NEMT Trends & Statistics to Know in 2024
21 NEMT Trends & Statistics to Know in 202421 NEMT Trends & Statistics to Know in 2024
21 NEMT Trends & Statistics to Know in 2024Traumasoft LLC
 
Medical Malpractice & Medical Negligence (1).pptx
Medical Malpractice & Medical Negligence (1).pptxMedical Malpractice & Medical Negligence (1).pptx
Medical Malpractice & Medical Negligence (1).pptxanukshadias2
 
Artificial Intelligence in Healthcare: Challenges, Risks, Benefits
Artificial Intelligence in Healthcare: Challenges, Risks, BenefitsArtificial Intelligence in Healthcare: Challenges, Risks, Benefits
Artificial Intelligence in Healthcare: Challenges, Risks, BenefitsIris Thiele Isip-Tan
 
Toothpaste for bleeding gums and sensitive teeth. Teeth whitening, Mouthwash....
Toothpaste for bleeding gums and sensitive teeth. Teeth whitening, Mouthwash....Toothpaste for bleeding gums and sensitive teeth. Teeth whitening, Mouthwash....
Toothpaste for bleeding gums and sensitive teeth. Teeth whitening, Mouthwash....sharyurangari111
 
Hematinics and Erythropoietin- Pharmacology of Hematinics
Hematinics and Erythropoietin- Pharmacology of HematinicsHematinics and Erythropoietin- Pharmacology of Hematinics
Hematinics and Erythropoietin- Pharmacology of Hematinicsnetraangadi2
 
Assisted Living Care Residency - PapayaCare
Assisted Living Care Residency - PapayaCareAssisted Living Care Residency - PapayaCare
Assisted Living Care Residency - PapayaCareratilalthakkar704
 
ACCA Version of AI & Healthcare: An Overview for the Curious
ACCA Version of AI & Healthcare: An Overview for the CuriousACCA Version of AI & Healthcare: An Overview for the Curious
ACCA Version of AI & Healthcare: An Overview for the CuriousKR_Barker
 
Living Well Every Day: Lyons Wellness Practice | Nurtures Your Complete Health
Living Well Every Day: Lyons Wellness Practice | Nurtures Your Complete HealthLiving Well Every Day: Lyons Wellness Practice | Nurtures Your Complete Health
Living Well Every Day: Lyons Wellness Practice | Nurtures Your Complete HealthLyons Health
 
Artificial Intelligence: Diabetes Management
Artificial Intelligence: Diabetes ManagementArtificial Intelligence: Diabetes Management
Artificial Intelligence: Diabetes ManagementIris Thiele Isip-Tan
 

Dernier (20)

The Power of Active listening - Tool in effective communication.pdf
The Power of Active listening - Tool in effective communication.pdfThe Power of Active listening - Tool in effective communication.pdf
The Power of Active listening - Tool in effective communication.pdf
 
Eating Disorders in Athletes I Sports Psychology
Eating Disorders in Athletes I Sports PsychologyEating Disorders in Athletes I Sports Psychology
Eating Disorders in Athletes I Sports Psychology
 
Empathy Is a Stress Response - Choose Compassion instead
Empathy Is a Stress Response - Choose Compassion insteadEmpathy Is a Stress Response - Choose Compassion instead
Empathy Is a Stress Response - Choose Compassion instead
 
Annual Training
Annual TrainingAnnual Training
Annual Training
 
LEUKODYSTROPHY FINAL.pptx sms medical jaipur
LEUKODYSTROPHY FINAL.pptx sms medical jaipurLEUKODYSTROPHY FINAL.pptx sms medical jaipur
LEUKODYSTROPHY FINAL.pptx sms medical jaipur
 
CECT NECK NECK ANGIOGRAPHY CAROTID ANGIOGRAPHY
CECT NECK NECK ANGIOGRAPHY CAROTID ANGIOGRAPHYCECT NECK NECK ANGIOGRAPHY CAROTID ANGIOGRAPHY
CECT NECK NECK ANGIOGRAPHY CAROTID ANGIOGRAPHY
 
LARYNGEAL CANCER.pptx Prepared by Neha Kewat
LARYNGEAL CANCER.pptx  Prepared by Neha KewatLARYNGEAL CANCER.pptx  Prepared by Neha Kewat
LARYNGEAL CANCER.pptx Prepared by Neha Kewat
 
Blood(The Applied Physiology) for Nurses.pptx
Blood(The Applied Physiology) for Nurses.pptxBlood(The Applied Physiology) for Nurses.pptx
Blood(The Applied Physiology) for Nurses.pptx
 
Experience the Power of Chiropractic in Maui
Experience the Power of Chiropractic in MauiExperience the Power of Chiropractic in Maui
Experience the Power of Chiropractic in Maui
 
SCOPE OF CRITICAL CARE ORGANIZATION
SCOPE OF CRITICAL CARE ORGANIZATIONSCOPE OF CRITICAL CARE ORGANIZATION
SCOPE OF CRITICAL CARE ORGANIZATION
 
Govt releases guidelines to curb unethical pharma sector practices.pdf
Govt releases guidelines to curb unethical pharma sector practices.pdfGovt releases guidelines to curb unethical pharma sector practices.pdf
Govt releases guidelines to curb unethical pharma sector practices.pdf
 
21 NEMT Trends & Statistics to Know in 2024
21 NEMT Trends & Statistics to Know in 202421 NEMT Trends & Statistics to Know in 2024
21 NEMT Trends & Statistics to Know in 2024
 
Medical Malpractice & Medical Negligence (1).pptx
Medical Malpractice & Medical Negligence (1).pptxMedical Malpractice & Medical Negligence (1).pptx
Medical Malpractice & Medical Negligence (1).pptx
 
Artificial Intelligence in Healthcare: Challenges, Risks, Benefits
Artificial Intelligence in Healthcare: Challenges, Risks, BenefitsArtificial Intelligence in Healthcare: Challenges, Risks, Benefits
Artificial Intelligence in Healthcare: Challenges, Risks, Benefits
 
Toothpaste for bleeding gums and sensitive teeth. Teeth whitening, Mouthwash....
Toothpaste for bleeding gums and sensitive teeth. Teeth whitening, Mouthwash....Toothpaste for bleeding gums and sensitive teeth. Teeth whitening, Mouthwash....
Toothpaste for bleeding gums and sensitive teeth. Teeth whitening, Mouthwash....
 
Hematinics and Erythropoietin- Pharmacology of Hematinics
Hematinics and Erythropoietin- Pharmacology of HematinicsHematinics and Erythropoietin- Pharmacology of Hematinics
Hematinics and Erythropoietin- Pharmacology of Hematinics
 
Assisted Living Care Residency - PapayaCare
Assisted Living Care Residency - PapayaCareAssisted Living Care Residency - PapayaCare
Assisted Living Care Residency - PapayaCare
 
ACCA Version of AI & Healthcare: An Overview for the Curious
ACCA Version of AI & Healthcare: An Overview for the CuriousACCA Version of AI & Healthcare: An Overview for the Curious
ACCA Version of AI & Healthcare: An Overview for the Curious
 
Living Well Every Day: Lyons Wellness Practice | Nurtures Your Complete Health
Living Well Every Day: Lyons Wellness Practice | Nurtures Your Complete HealthLiving Well Every Day: Lyons Wellness Practice | Nurtures Your Complete Health
Living Well Every Day: Lyons Wellness Practice | Nurtures Your Complete Health
 
Artificial Intelligence: Diabetes Management
Artificial Intelligence: Diabetes ManagementArtificial Intelligence: Diabetes Management
Artificial Intelligence: Diabetes Management
 

Sudden cardiac death

  • 1. SUDDEN CARDIAC ARREST DR. D. B. PAHLAJANI MD,FACC,FSCAI Consultant Cardiologist & Chief of Cardiac Catherization Laboratory, Breach Candy Hospital Mumbai
  • 2. Sudden Cardiac Death: Definition • “Sudden cardiac death is natural death due to cardiac causes, heralded by abrupt loss of consciousness within one hour of the onset of acute symptoms, as in an individual with or without known pre-existing heart disease, but in whom the time and mode of death are unexpected”. Gaziano JM in Braunwald Zipes Libby Heart Disease,6th ed.W.B. Saunders 2001:1
  • 3. The Epidemic of Sudden Cardiac Arrest
  • 4. Sudden Cardiac Arrest • Accounts for 63% of all cardiac related deaths in the US1 . • One of the most common causes of death in developed countries: 1 MMWR. Vol 51(6) Feb. 15, 2002. 2 Braunwald E, ed. Heart Disease: A Textbook of Cardiovascular Medicine. 5th Ed. New York: WB Saunders. 1997: 742-779. 3 Zheng Z. Circulation. 2001;104:2158- 2163. 4 Vreede-Swagemakers JJ et al. J Am Coll Cardiol 1997; 30: 1500-1505. GeographyGeography IncidenceIncidence SurvivalSurvival Worldwide 3,000,0002 <1%2 US 450,0003 ~5%2 W. Europe 400,0004 <5%4
  • 5. Magnitude of SCA in the US 42,156 450,000 40,600 157,400 167,366 1 U.S. Census Bureau, Statistical Abstract of the United States: 2001. 2 American Cancer Society, Inc., Surveillance Research, Cancer Facts and Figures 2001. 3 2002 Heart and Stroke Statistical Update, American Heart Association. AIDS1 Breast Cancer2 Lung Cancer2 Stroke3 Sudden Cardiac Arrest 4 SCA claims more lives each year than these other diseases combined The #1 Cause of Death
  • 6. Resuscitated Cardiac Arrest- Prognosis • 48749 STEMI • 5308 (10.9%) CA • 157 (29.3%) died on the day of admission • Increased risk of death during index hosp (HR 3.69 • 30 days HR 1.5 • Following 30 days HR 1.1 Albert Alahmar et al,Heart,April 24,2014
  • 7. Etiology of Sudden Cardiac Death
  • 8. Coronary Heart Disease • An estimated 13 million people had CHD in the U.S. in 2002. 1 • Sudden death was the first manifestation of coronary heart disease in 50% of men and 63% of women. 1 • CHD accounts for at least 80% of sudden cardiac deaths in Western cultures.3 1 American Heart Association. Heart Disease and Stroke Statistics— 2003 Update. Dallas, Tex.: American Heart Association; 2002. 2 Adapted from Heikki et al. N Engl J Med, Vol. 345, No. 20, 2001. 3 Myerberg RJ. Heart Disease, A Textbook of Cardiovascular Medicine. 6th ed. P. 895. Etiology of Sudden Cardiac DeathEtiology of Sudden Cardiac Death2,32,3OTHERS * ion-channel abnormalities, valvular or congenital heart disease, other causes 80% Coronary Heart Disease 15% Cardiomyopathy 5% Others*
  • 9. Arrhythmic Cause of SCD Albert CM. Circulation. 2003;107:2096-2101. 12% Other Cardiac Cause 88% Arrhythmic Cause
  • 10. Bayés de Luna A. Am Heart J. 1989;117:151-159. Underlying Arrhythmias of Sudden Cardiac Arrest Bradycardia 17% VT 62% Primary VF 8% Torsades de Pointes 13%
  • 11. Heart Failure and Sudden Cardiac Death
  • 12. Incidence of SCD in Specific Populations and Annual SCD Numbers Adapted from: Myerburg RJ. Sudden Cardiac Death: Exploring the Limits of Our Knowledge. J Cardiovasc Electrophysiol Vol. 12, pp. 369-381, March 2001. 300,000200,000100,0000 Incidence of Sudden Deaths Per Year (number) Multiple risk subgroups Patients with any previous coronary event Patients with ejection fraction <35% or CHF Cardiac arrest, VT/VF survivors High-risk post-MI subgroups General adult population 3025201050 Incidence of Sudden Death (% of group) MADIT, MUSTT, MADIT II AVID, CASH, CIDS SCD-HeFT
  • 13. Heart Failure and Sudden Death 5 8 7 15 0 2 4 6 8 10 12 14 16 Age-adjustedannual rate/1000 Women Men SCD-NoCHF SCD-CHF During a 39-year follow-up of subjects in the Framingham Heart Study, the presence of CHF significantly increased sudden death and overall mortality in both men and women.1 1 Redrawn from Kannel WB, Wilson PWF, D'Agostino RB, Cobb J. Sudden coronary death in women. Am Heart J 1998 Aug; 136: 205-212 60-115% increase in sudden death if CHF present.
  • 14. Severity of Heart Failure Modes of Death MERIT-HF Study Group. Effect of Metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL randomizedMERIT-HF Study Group. Effect of Metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL randomized intervention trial in congestive heart failure (MERIT-HF).intervention trial in congestive heart failure (MERIT-HF). LANCET.LANCET. 1999;353:2001-07.1999;353:2001-07. 12%12% 24%24% 64%64% CHFCHF OtherOther SuddenSudden DeathDeath n = 103n = 103 NYHA IINYHA II 26%26% 15%15% 59%59% CHFCHF OtherOther SuddenSudden DeathDeath n = 103n = 103 NYHA IIINYHA III 56%56% 11%11% 33%33% CHFCHF OtherOther SuddenSudden DeathDeath n = 27n = 27 NYHA IVNYHA IV The greatest opportunity for SCD prevention is in patients that have mild to moderate CHF.
  • 15. 1 Moss A, et al. N Engl J Med. 1996;335:1933–40. 2 Buxton, A, et al; N Engl J Med. 1999;341:1882–90. 3 AVID Investigators; N Engl J Med. 1997;337:1576–83. 4 Moss, A. et al; N Engl J Med. 2002;346:877–83. MADIT1 (n=196) MADIT-II2 (n=1232) MUSTT3 (n=704) Age 63 64 68 LVEF 0.26 0.23 0.30 NYHA I 37% 39% 37% NYHA II or III 63% 57% 63% NYHA IV Excluded 4% Excluded CAD (%) 100 100 100 Previous CABG/PTCA (%) 73/27 60/45 56/23 Post-MI trials are not heart failure trials but… … there’s a high % of symptomatic heart failure and LV dysfunction in the post-MI trials
  • 17.  150 Sudden Cardiac Deaths per 100,000 persons annually in industrialized world.  40% of SCDs occur in people with no prior history of heart disease.  SCD accounts for more than 50% of cardiac mortality.  Autopsies revealed 90% victims have CAD.  Age above 40 yrs. Incidence of Sudden Cardiac Death
  • 18.  Prior Episode of V.TACH  Low LVEF.  Previous Myocardial Infarction.  Coronary Artery Disease  Family History of SCD.  Cardiomyopathy  Congestive Heart Failure  Long QT Syndrome.  Right Ventricular Dysplasia. Risk Factors of Sudden Cardiac Death
  • 19.  % Witnessed VF Patients Surviving to Hospital Discharge 49% 7% 74% 0% 10% 20% 30% 40% 50% 60% 70% 80% Receiving shock <3 min. after collapse (26 / 35) Receiving shock >3 min. after collapse (27 / 55) National average Sudden Cardiac Arrest (SCA) “Chain of Survival” Third link – Early Defibrillation
  • 20. SCD Rates in Post-MI Patients with LV Dysfunction 21 19.8 14 10 7 16 16 12 9.4 28 18 20 28 0 10 20 30 TRACE CAPRICORN EMIAT MADIT MUSTT Inducible MUSTT Registry MADIT II* ControlGroupMortalityat2years Total Mortality Arrhythmic Mortality N Engl J Med 1995; 333: 1670-6. CAPRICORN: Lancet 2001; 357: 1385-90. Lancet 1997; 349: 667-74. MADIT: Moss AJ. N Engl J Med. 1996;335:1933-40. MUSTT: 1) Buxton AE. N Engl J Med. 1999;341:1882-90. 2) Buxton AE, et al. N Engl J Med 2000; 342: 1937-45. MADIT-II: 1) Moss AJ. N Engl J Med. 2002;346:877-83, 2) Arrhythmic mortality data from: Moss AJ. Presented at ACC Late Breaking Clinical Trials, March 2002. Total Mortality ~20-30%; SCD accounts for ~50% of the total deaths.
  • 21. SCD Rates in CHF Patients with LV Dysfunction 17 8 20 15 9 19 7 6 4 11 0 10 20 30 CHF-STAT GESICA SOLVD V-HeFT I MERIT-HF CIBIS-II CARVEDILOL-US ControlGroupMortality Total Mortality Sudden Death Total Mortality ~15-40%; SCD accounts for ~50% of the total deaths. 12 months 16 months41.4 months 27 months13 months45 months 6 months N Engl J Med 1995; 333: 77-82. GESICA: Doval, HC. Lancet. 1994. Circulation. 1999; 100: 1311-1315. Lancet 1999; 353: 2001-07. N Engl J Med 1996; 334: 1349-55.

Notes de l'éditeur

  1. Death is universally arrhythmic sudden death
  2. Focusing on cardiac arrest survivors is NOT the answer because these patients represent only a very small percentage of the total number of patients who experience SCA each year. To address the greatest number of patients, primary prevention therapies will be required. Today, we can effectively identify/treat a very small portion of the total number of patients who experience SCA. SCD-HeFT may significantly increase our ability to treat high-risk heart failure patients.
  3. The proportionate contribution of SCD to total mortality in HF associated with reduced left ventricular function has not changed substantially between the Framingham data and now. Kannel WB, Wilson PWF, D&amp;apos;Agostino RB, Cobb J. Sudden coronary death in women. Am Heart J 1998 Aug; 136: 205-212
  4. Interestingly, most patients who suffer from sudden cardiac death (64%) are the patients who are minimally symptomatic with Class II heart failure. The sickest, most symptomatic patient (Class IV) experience heart failure deaths (56%) from pump failure, rather than sudden cardiac death (33%). It is important to remember that although it can be said that a heart failure patient in NYHA class II may have a higher risk of SCD, their relative annual risk of dying is less than the other NYHA classes. The SCD-HeFT Trial (Sudden Cardiac Death in Heart Failure Trial) which enrolled NYHA class II and III patients, hopes to answer whether patients in these classes are truly at a higher risk for SCD and need protection.
  5. TRACE: Kober L, et al. N Engl J Med 1995; 333: 1670-6. CAPRICORN: The CAPRICORN Investigators. Lancet 2001; 357: 1385-90. EMIAT: Julian DG, et al. Lancet 1997; 349: 667-74. MADIT: Moss AJ. N Engl J Med. 1996;335:1933-40. MUSTT: 1) Buxton AE. N Engl J Med. 1999;341:1882-90. 2) Buxton AE, et al. Journal of Interventional Cardiac Electrophysiology 9, 203-206, 2003. 3) Buxton AE, et al. N Engl J Med 2000; 342: 1937-45. MADIT-II: 1) Moss AJ. N Engl J Med. 2002;346:877-83, 2) Arrhythmic mortality data from: Moss AJ. Presented at ACC Late Breaking Clinical Trials, March 2002.
  6. CHF-STAT: Singh SN, et al. Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. N Engl J Med 1995; 333: 77-82. GESICA: Doval, HC. Lancet. 1994. SOLVD: Cooper H, et al. Dirueticsand Risk of Arrhythmic Death in Patients with Left Ventricularl Dysfunction. Circulation. 1999; 100: 1311-1315. V-HEFT I: Goldman S, Johnson G, Cohn JN, Cintron G, Smith R, Francis G. Mechanism of death in heart failure. The Vasodilator-Heart Failure Trials. The V-HeFT VA Cooperative Studies Group. Circulation. 1993 Jun;87(6 Suppl):VI24-31 MERIT-HF: Effect of metoprolol CR/XL in chronic heart failure: metoprolol CR/XL randomized intervention trial in Congestive Heart Failure (MERIT-HF). Lancet 1999; 353: 2001-07. CIBIS II: The Cardiac Insufficiency Bisoprolol Study II (CIBIS II): a randomized trial. THE LANCET: 353: 9-13. CARVEDILOL-US: The Effect of Carvedilol on Morbidity and Mortality in Patients with Chronic Heart Failure. N Engl J Med 1996; 334: 1349-55.